SNP discovery and typing technologies for pharmacogenomics.

Area of Science:

• Genetics and Genomics
• Pharmacogenomics
• Biotechnology

Background:

• Genetic variation in the human genome is primarily due to single nucleotide polymorphisms (SNPs).
• An estimated ten million SNPs exist, with three million differing between any two individuals.
• These genetic differences significantly influence human phenotypes, including disease susceptibility and drug responses.

Purpose of the Study:

• To review the development of high-throughput SNP discovery and typing technologies.
• To highlight the importance of large-scale association studies in drug development.
• To emphasize the role of genetic variation in personalized medicine and tailored drug regimens.

Main Methods:

• Review of current high-throughput technologies for SNP discovery.
• Analysis of SNP typing methodologies.
• Discussion of the application of these technologies in large-scale association studies.

Main Results:

• The review details advancements in SNP discovery and typing, enabling large-scale genetic studies.
• These technologies facilitate the identification of genetic variations linked to complex phenotypes.
• The findings underscore the growing utility of genetic information in tailoring medical treatments.

Conclusions:

• High-throughput SNP technologies are essential for understanding human genetic variation.
• These advancements support personalized medicine by enabling genotype-specific drug development and dosing.
• Continued development in SNP analysis is critical for future biomedical research and clinical applications.